Miyahara Nobuaki
Department of Medical Technology, Okayama University Graduate School of Health Sciences.
Department of Allergy and Respiratory Medicine, Okayama University Hospital.
Nihon Yakurigaku Zasshi. 2020;155(6):360-363. doi: 10.1254/fpj.20036.
Neuropeptide Y (NPY) is a neurotransmitter that is widely expressed in the brain and peripheral nervous system. Various immune cells express the receptor for NPY, Y1 receptor. NPY modulates these cells via its Y1 receptor, and involvement of NPY in the pathophysiology of bronchial asthma, has been reported. Increased plasma levels of NPY in asthmatic patients have been reported. NPY polymorphisms are associated with an increased risk for asthma in overweight subjects and young adults. We and other researchers have reported that using murine models of allergic airway responses, NPY and Y1 receptor play critical roles for the development of allergic airway inflammation and airway hyperresponsiveness. Therefore, manipulating NPY-Y1 pathway represents a novel therapeutic target to control allergic airway responses, and might be beneficial for treatment of bronchial asthma.
神经肽Y(NPY)是一种神经递质,在大脑和外周神经系统中广泛表达。各种免疫细胞表达NPY的受体,即Y1受体。NPY通过其Y1受体调节这些细胞,并且已有报道称NPY参与支气管哮喘的病理生理学过程。有报道称哮喘患者血浆中NPY水平升高。NPY基因多态性与超重受试者和年轻人患哮喘的风险增加有关。我们和其他研究人员报道,使用过敏性气道反应的小鼠模型,NPY和Y1受体在过敏性气道炎症和气道高反应性的发展中起关键作用。因此,操纵NPY-Y1通路代表了控制过敏性气道反应的一种新的治疗靶点,可能对支气管哮喘的治疗有益。